Shandong Kangqiao knocked on the door of the EU market!
With the coming Oil & Gas Asia Exhibition in Pakistan, ECHEMI rolls out a new bulk purchasing activity for its new and old customers. This activity will be valid before March 16 when the exhibition come to the end. The more you buy, the more money you will save.
How to join this bulk purchasing?
You can enjoy the most favorable prices via three steps:
First, you should come to the home page of ECHEMI, then you can see the the following page:
Second, input your demand and submit the inquiry.
Third, ECHEMI will give you a reply within 1 working day after receiving your inquiry.
Opportunity knocks but once! Come on, seize this opportunity right now!
Looking for chemical products? Let suppliers reach out to you!
You May Interested In
β-Nicotinamide Adenine Dinucleotide High Quality NAD+ CAS 53-84-9 Exclusive Production Factory CAS NO.53-84-9
$75/UNIT FOB
2026-06-21
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Novo Nordisk Sounds the Alarm: Growth Headwinds Loom Over Global Operations in 2026
-
Pharma’s Tightrope in 2026: Safety, Competition and the Future of Obesity Treatment Innovation
-
FDA Orders Removal of “Suicidality Warning”: Are Weight-Loss Blockbusters Finally Cleared—or Is Regulators Giving the Market a Reality Check?
-
Strides Pharma Reports Strong Q2 as Net Profit Surges 82%
-
FDA Names Veteran Oncology Regulator Pazdur as Director of Drug Review Center
-
India Strengthens Drug Approval Oversight with Expanded CDSCO Powers
-
Pfizer Sues Metsera and Novo Nordisk Over Rival Obesity Drug Strategy
-
Cipla CEO Calls Tirzepatide a High-Science Product with Strong Market Outlook
-
Pfizer Seen Holding Strategic Edge in Bidding Battle for Metsera
-
Canada Issues Non-Compliance Notice to Dr. Reddy’s on Semaglutide Generic
Recommend Reading
-
Novo Nordisk Enters High-Stakes Bidding War with Pfizer for Metsera
-
U.S. Health Chief Says No Evidence Linking Tylenol to Autism
-
Merck and Eisai Halt Late-Stage Trial for Liver Cancer Therapy
-
MENA Pharmaceutical Regulatory Updates 2026: Key Compliance Changes for Global Pharma Companies
-
Lilly Eyes Fast-Track Approval for Oral Weight-Loss Drug in U.S.
-
Demand Continues to Weaken, China's Acrylonitrile Market Fluctuates Downward
-
India Swings the Tariff Axe at Made-in-China: Epoxy Resins Are Just the Beginning—The Road for Chinese Chemicals Abroad Is No Longer Smooth
-
This Week's Styrene Market Slightly Declined (4.13-4.17) in China
-
At the end of the month, the 180CST fuel oil market in China remains stable
-
This week, the Aniline market in China saw a slight increase (4.13-4.17)